Accolade Stock Tumbles On Q1 Earnings, Weak Guidance: What You Need To Know - Accolade (NASDAQ:ACCD)

　　Accolade IncACCD shares are tanking in Thursdays after-hours session after the company reported financial results for its fiscal first quarter and issued weak guidance.

• Q1 Revenue:$110.47 million, beat estimates of $105.19 million

• Q1 EPS: loss of 35 cents, beat estimates for a loss of 48 cents

　　“We will continue to push our leadership in Healthcare AI and a proven engagement model that is driving sustainable and profitable growth. Our focus remains on delivering a superior member experience and executing against our long term objectives to make an impact of all of our members lives,” said Rajeev Singh, chairman and CEO of Accolade.

　　Outlook:Accolade expects fiscal second-quarter revenue to be between $104 million to $106 million versus estimates of $113.18 million. The company sees full-year 2025 revenue in the range of $460 million to $475 million versus estimates of $490.47 million.

　　Accolade anticipates a second-quarter adjusted EBITDA loss of $8 million to $10 million. The company expects full-year adjusted EBITDA to be between $15 million and $20 million.

　　“We are de-risking our full year revenue forecast and focusing our investments on margin expansion and revenue opportunities that support our profitability objectives,” said Steve Barnes, CFO of Accolade.

　　Management will discuss these results on a conference call slated for 4:30 p.m. ET.

　　ACCD Price Action:At the time of publication, Accolade shares were down 26.60% at $4.69 in after-hours trading, according to Benzinga Pro.

　　Photo: 3844328 from Pixabay.

　　© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.